London
19 °C
Manchester
Glasgow
17 °C
Dublin
Belfast
Washington
27 °C
Denver
Atlanta
Dallas
Houston Texas
New Orleans
El Paso
Phoenix
Los Angeles
17 °C
22 °C
22 °C
7 °C
28 °C
18 °C
Featured
Last news
Russia bans Nobel-winning rights group, raids independent newspaper, in one day
Russia banned the Nobel Prize-winning human rights group Memorial and raided the offices of the independent newspaper Novaya Gazeta Thursday, in fresh blows to already diminished civil liberties in the country.
Venezuela police clash with protesters demanding salary rises
Venezuelan police fired tear gas on Thursday to disperse around 2,000 protesters who marched towards the presidential palace to demand salary and pension increases, AFP reporters saw.
Melania Trump blasts 'lies' linking her to Epstein
US First Lady Melania Trump made a surprise statement on Thursday denying any knowledge of Jeffrey Epstein's abuse, or that she herself was a victim of the convicted sex offender.
Melania Trump denies any links to Epstein abuse
US First Lady Melania Trump on Thursday made a surprise statement denying unspecified allegations about her and Jeffrey Epstein, a scandal that her husband President Donald Trump has long downplayed.
Venezuela police tear-gas protesters demanding salary rises
Venezuelan police fired tear gas on Thursday to disperse around 2,000 protesters who marched towards the presidential palace to demand salary and pension increases, AFP reporters saw.
Believers rejoice as Jerusalem's holy sites re-open
Just before 5 am at Jerusalem's Al-Aqsa Mosque compound, a Muslim worshipper prayed in tears. A few hours later, similar emotion overcame Christians and Jews as the city's holy sites reopened following the truce with Iran.
Shallow Indonesian quake damages houses, injures residents
A shallow 4.9-magitude earthquake struck eastern Indonesia overnight, damaging dozens of homes and injuring multiple people, an official said Thursday.
US-Iran truce enters second day as war flares in Lebanon
The fragile truce between Iran and the United States entered its second day on Thursday, with Tehran threatening to resume hostilities as Israel launched a major bombardment of Lebanon.
Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
Click here to register
Queue Ventures Announces TSX Conditional Approval
Not for distribution to United States newswire services or for dissemination in the United States.
US, Iran truce hangs in balance as war flares in Lebanon
The fragile two-week truce between Iran and the United States was hanging in the balance on Wednesday, with Tehran threatening to resume hostilities as Israel launched a major bombardment of Lebanon.
Turkey puts 11 on trial for LGBT 'obscenity'
Eleven leaders of a Turkish LGBT rights group went on trial Wednesday on charges of "obscenity" and "violating the protection of the family", their lawyer told AFP.
Brazilian police dog sniffs out 48 tons of marijuana in record bust
Brazilian police on Wednesday seized a record 48 tons of marijuana in a favela in Rio de Janeiro, uncovered by chance by a sniffer dog during a regular operation against criminal factions.
'Unfinished business': Opponents anxious, bitter after Iran ceasefire
President Donald Trump promised "regime change" in Iran but the Islamic republic has emerged intact from the US-Israeli war, leaving opponents and activists disappointed and frightened.
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Topline results expected within a month and may complement positive results of a study of crofelemer for treatment of cancer therapy-induced diarrhea (CTD) in dogs receiving neratinib - a targeted tyrosine kinase inhibitor (TKI)
CBMJ Completes Patriot.TV Asset Sale, Reduces Capital Requirements and Accelerates Path Toward Contemplated Strategic Acquisition
Completed transaction enhances financial flexibility, sharpens strategic focus and positions CBMJ for its next chapter.
Trump suspends Iran bombing for two weeks, after apocalyptic threats
US President Donald Trump said Tuesday he was suspending bombing of Iran for two weeks but that Tehran must reopen the key Strait of Hormuz, barely an hour before his apocalyptic deadline to destroy the country was set to expire.
Graft trial of Spanish PM's ex-top aide begins
A corruption trial of Spanish Prime Minister Pedro Sanchez's former right-hand man opened on Tuesday, a case that has rocked a Socialist-led minority government that has prioritised stamping out graft.
French high-speed train slams into truck, killing TGV driver
A French high-speed train crashed into a truck carrying a military vehicle in northern France on Tuesday, killing the driver of the TGV and badly injuring two people, officials said.
Gunman killed, 2 wounded in shootout outside Israel's Istanbul consulate
A gunman was killed and two others wounded in a shootout Tuesday with police outside the Israeli consulate in Istanbul, the local governor said, adding two officers were lightly wounded.
Train driver killed, two critically injured as French TGV collides with truck
A French high-speed train crashed into a truck carrying military equipment in northern France on Tuesday, killing the driver of the TGV and critically injuring two people, officials said.
New strikes in Tehran as deadline looms for Trump threat to infrastructure
New strikes rocked Tehran on Tuesday with Iran showing no sign of backing down as a US deadline loomed for it to reopen the Strait of Hormuz or have its civilian infrastructure "decimated", according to President Donald Trump.
Olympic cyclist Rohan Dennis breaks silence after wife's death
Australian former world champion cyclist Rohan Dennis said on Tuesday he loved his wife and never wanted to hurt her in his first public comments since receiving a suspended sentence over her death.
Polaris Renewable Energy Announces Q1 2026 Investor Call Details
TORONTO, ON / ACCESS Newswire / April 7, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") is pleased to announce it will be holding its Earnings Conference Call and Webcast to report its Q1 2026 Earnings Results on Thursday, May 7th, 2026, at 10:00 am EST.
Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
Company also announces Marketing Engagement
Queue Ventures Announces Mailing of Management Information Circular
Not for distribution to United States newswire services or for dissemination in the United States.
Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
SHELTON, CT / ACCESS Newswire / April 7, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that it has filed an application for "Rare Pediatric Disease Drug" Designation (RPDD) for NV-387 as a Treatment for Measles with the US FDA Office of Orphan Products Development (OOPD). This RPDD application is expected to be joined together with the Orphan Drug Designation application for NV-387 as a Treatment for Measles that the Company has filed in February, 2026.
Jaguar Health Reports 2025 Financials
Net revenue increase of 5% in Q4 2025 vs. Q3 2025Jaguar received an up-front payment of $16Mof non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1 - Jaguar's commercialized crofelemer drugs - with an additional $2 million due upon completion of post-closing conditions; and has received $3.0 of up to $20 million in milestone payments and other future paymentsAgreement with Future Pak is fully aligned with Jaguar's strategy to concentrate crofelemer development efforts on human rare-disease intestinal failure indications moving forwardJaguar will appeal Nasdaq's March 5, 2026 noncompliance determination related to Nasdaq Listing Rule 5550(a)(2) at a hearing on April 7, 2026; delisting is stayed pending the panel's final decisionREMINDER: Friday, April 10, Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q4 2025 financials and company updates; Click here to register
BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries
VANCOUVER, BC / ACCESS Newswire / April 7, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the official registration of unitary effect for European Patent No. 4539857 covering the Company's proprietary sublingual cladribine oral thin film (ODF) platform.
Trump says Iran ceasefire proposal 'not good enough'
US President Donald Trump said Monday that a proposed 45-day ceasefire with Iran was a "very significant step" but "not good enough" for him to sign, as Iranian officials vowed to keep fighting.
In El Salvador's mass trials, 'the innocent pay for the guilty'
Wearing white uniforms, their heads shaved, rows of bewildered-looking men are beamed by video link from prisons across El Salvador into a courtroom conducting a mass trial of alleged gang members.
NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study
LEXINGTON, KY / ACCESS Newswire / April 6, 2026 / NX Development Corp (NXDC) is pleased to announce that after successfully completing the data analysis of our MEN-301 Study of the use of Gleolan® (aminolevulinic acid HCl) to enhance visualization of newly diagnosed or recurrent meningioma, we have submitted these data to the FDA for review as part of an efficacy supplement to our Gleolan New Drug Application (NDA).